Post

In-process control by HPLC ensures impurity levels stay below 0.10%.

Single-use bioreactor technology cut our turnaround time by 40%.

The SPR binding kinetics showed slow-on/slow-off behavior, ideal for once-daily dosing.

Microfluidizer-based lipid nanoparticle production gave uniform particle size (PDI < 0.1).

The covalent organic framework adsorbed 2.5 mmol/g of CO2 at 0.15 bar.